History of Semaglutide Originally developed to treat diabetes, Semaglutide is a long-lasting medication that has a strong safety profile
MEN2 Syndrome This is a rare genetic condition that raises thyroid cancer risk
While early GLP1 drugs focused primarily on diabetes, newer agents, such as tirzepatidebased therapies, have gained traction in treating obesity, raising efficacy expectations and increasing competitive dynamics
The bottom line: you can combine berberine and tirzepatide, but you need to do it with informed intentions, active blood sugar monitoring, appropriate dose sequencing, and a clear plan for managing GI side effects
GLP-1 users may differ from nonusers in ways that are not fully captured, such as socioeconomic status, health behaviors, disease severity, medication adherence, or access to care." Lakkis notes that the study also did not report how much weight participants lost, making it difficult to determine how much of the benefit may have been driven by weight reduction itself